forgemax.FORGED. TESTED. PROVEN.
Decaver 250mg/ml 10ml Vial by Vermodje
Authenticity Verified

Decaver 250mg/ml 10ml Vial by Vermodje

Decaver by Vermodje is a 250 mg/ml Nandrolone Decanoate injectable depot, evaluated here specifically through the lens of Post-Cycle Therapy planning — the structured pharmacological protocol required to restore endogenous testosterone production after a Nandrolone-containing cycle. Because the decanoate ester generates a prolonged plasma clearance window, precise PCT timing relative to the final Decaver injection is the single most consequential variable in HPTA recovery. HPLC-verified potency and LAL endotoxin-tested batch release are confirmed at the Vermodje facility; each 10 ml multi-dose vial is crimped under aseptic conditions and carries a traceable Certificate of Analysis.

€42.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Delivers 250 mg of verified Nandrolone Decanoate per millilitre, allowing precise weekly dose calculations critical for PCT timing planning.
  • 10 ml multi-dose vial provides sufficient supply for a complete cycle with volume remaining for accurate dose-tapering in the final pre-PCT weeks.
  • HPLC-confirmed API potency ensures the milligram load driving HPTA suppression is exactly as labelled — eliminating guesswork from recovery timeline projections.
  • LAL endotoxin testing on every batch reduces inflammatory injection-site responses that can complicate monitoring during sensitive PCT windows.
  • Vermodje's aseptic fill-finish process maintains vial sterility across the 28-day in-use period typical of multi-dose oil-based protocols.
  • Traceable Certificate of Analysis accompanies each batch, providing practitioners with lot-specific documentation relevant to clinical bloodwork interpretation.
  • 250 mg/ml concentration minimises injection volume per dose, reducing tissue trauma during cycles where injection frequency must be managed around PCT scheduling.

Key takeaways

  • Wait 14–21 days after final Decaver injection before initiating SERM therapy.
  • Monitor prolactin alongside LH and FSH throughout Nandrolone PCT recovery.
  • Add cabergoline when bloodwork confirms prolactin elevation above reference range.
  • Track serum testosterone at weeks 4, 8, and 12 to confirm HPTA restoration.
  • Store opened Decaver vial at room temperature and discard after 28 days.

Nandrolone Decanoate and Post-Cycle Therapy: Why the Ester Determines Everything

Decaver delivers Nandrolone Decanoate at 250 mg per millilitre — a high-concentration injectable whose extended ester chain makes Post-Cycle Therapy timing fundamentally different from short-ester androgen protocols. Nandrolone Decanoate suppresses the hypothalamic-pituitary-testicular axis potently, and the ester prolongs active plasma exposure well beyond the final injection date, meaning PCT initiated too early will encounter residual suppressive nandrolone concentrations that blunt luteinising hormone (LH) and follicle-stimulating hormone (FSH) recovery. Compared to testosterone propionate, where PCT can begin as soon as three days post-final-injection, Nandrolone Decanoate typically requires a waiting window of fourteen to twenty-one days before selective oestrogen receptor modulators (SERMs) become pharmacologically effective.

The HPTA Suppression Mechanism and Its PCT Implications

Nandrolone's 19-nor structure binds hypothalamic androgen receptors and simultaneously elevates prolactin via progestogenic activity, creating a dual suppression pathway that SERMs alone do not fully address. Vermodje's Decaver at 250 mg/ml means a practitioner using 300 mg per week draws only 1.2 ml per injection, but those milligrams accumulate in depot tissue and continue releasing free nandrolone for up to three weeks after the final dose. A well-structured Decaver PCT protocol therefore involves three sequential phases: a clearance window (weeks 1–3 post-final-injection), a SERM initiation phase (typically Tamoxifen at 20–40 mg/day or Clomiphene at 50 mg/day, beginning at week 3–4), and a prolactin-management phase using a dopamine agonist such as cabergoline at 0.25–0.5 mg twice weekly where bloodwork indicates elevated prolactin. Serial serum LH, FSH, and total testosterone panels — ideally drawn at weeks 4, 8, and 12 of recovery — provide the quantitative benchmarks that determine when HPTA restoration is clinically sufficient.

Bloodwork-Driven Recovery Timelines

Full HPTA recovery after a Nandrolone Decanoate cycle, confirmed by LH returning above 2 mIU/ml and total testosterone exceeding 400 ng/dL without exogenous support, typically requires eight to fourteen weeks of structured PCT in clinical observation data. Decaver's 250 mg/ml concentration requires no extra containers to complete a standard cycle, centralising the suppressive load in one accountable vial whose batch Certificate of Analysis documents the exact API input driving the hormonal impact practitioners must plan to reverse.

Usage

  1. Establish your PCT exit date before starting the cycle: count back 14–21 days from that date to identify your final Decaver injection window.
  2. Draw each dose using a 3 ml syringe and 21-gauge needle; confirm the volume against the 250 mg/ml concentration (e.g., 300 mg = 1.2 ml) before injecting.
  3. In the final two weeks of your cycle, consider reducing your weekly Decaver dose to 200 mg to compress the ester clearance window and allow earlier SERM initiation.
  4. During the clearance window (days 1–21 post-final-injection), obtain a baseline blood panel: LH, FSH, total testosterone, prolactin, and oestradiol — these values anchor your PCT monitoring programme.
  5. Initiate your SERM (Tamoxifen or Clomiphene) at week 3–4 post-final-injection; if bloodwork shows prolactin above range, add cabergoline at the same time rather than waiting for symptomatic signs.
  6. Retest LH, FSH, and total testosterone at PCT weeks 4, 8, and 12; discontinue PCT only when total testosterone exceeds 400 ng/dL and LH reads above 2 mIU/ml on two consecutive panels taken two weeks apart.

Warnings

Contraindications: Decaver must not be used by individuals with androgen-sensitive prostate or breast pathology, active hepatic disease, hypercalcaemia, or known hypersensitivity to Nandrolone Decanoate or sesame/arachis oil excipients. Pregnancy and breastfeeding are absolute contraindications. Paediatric use is contraindicated due to premature epiphyseal closure risk.

Side_Effects: HPTA suppression is the primary PCT-relevant adverse effect; severity correlates with cycle duration and weekly dose. Prolactin elevation (unique to 19-nor compounds), fluid retention, lipid profile disruption (HDL reduction, LDL elevation), haematocrit increase, and injection-site reactions are all dose-dependent. Androgenic effects including acne and scalp thinning are lower in incidence than with testosterone but not absent.

Monitoring: Mandatory pre-cycle bloodwork: total testosterone, LH, FSH, prolactin, oestradiol, haematocrit, and a full lipid panel. Repeat mid-cycle at week 6–8. Obtain the PCT baseline panel during the clearance window (days 7–14 post-final-injection). Final recovery confirmation requires two sequential panels showing normalised LH, FSH, and testosterone without exogenous androgen support.

PCT: Post-Cycle Therapy after Decaver must not begin until 14–21 days after the final injection. The standard protocol is a SERM (Tamoxifen 20–40 mg/day or Clomiphene 50 mg/day) for 8–12 weeks. Elevated prolactin confirmed by bloodwork requires concurrent dopamine agonist therapy. Do not substitute AI (aromatase inhibitor) monotherapy for SERM-based PCT in Nandrolone recovery — the primary suppression mechanism is not oestrogen-mediated and AI alone will not restore LH/FSH output.

Frequently asked questions

How many weeks after the last Decaver injection should I wait before starting PCT?
Wait approximately fourteen to twenty-one days after your final Decaver injection before initiating SERMs. The decanoate ester continues releasing active nandrolone for roughly two to three weeks post-injection; starting PCT inside that window means your SERM is competing against still-suppressive plasma nandrolone, significantly reducing LH and FSH response and delaying HPTA recovery.
Which PCT drugs are recommended after a Nandrolone Decanoate cycle with Decaver?
A SERM — Tamoxifen at 20–40 mg/day or Clomiphene at 50 mg/day — forms the backbone of Decaver PCT. Because Nandrolone is a 19-nor compound with progestogenic activity, elevated prolactin is common; bloodwork showing prolactin above the normal reference range warrants adding cabergoline at 0.25 mg twice weekly alongside the SERM for the first four to six weeks of recovery.
How long does full testosterone recovery take after stopping Nandrolone Decanoate?
Clinical observation data indicates eight to fourteen weeks of structured PCT for total testosterone to return above 400 ng/dL without exogenous support, confirmed by serial LH/FSH panels. Recovery timeline is dose-dependent: longer cycles at higher weekly Decaver doses generate deeper HPTA suppression and require the upper end of this range. Bloodwork at weeks 4, 8, and 12 of PCT provides the quantitative milestones to track progress.
How do I draw an accurate dose from a 250 mg/ml Decaver 10 ml vial without wasting product?
Use a 3 ml luer-lock syringe with a 21-gauge draw needle to pull back from the vial. For a 250 mg dose draw exactly 1.0 ml; for 200 mg draw 0.8 ml. Swap to an injection needle before administering. Avoid insulin syringes for oils at this concentration — their smaller barrel makes accurate measurement of viscous oil difficult and increases plunger-seal stress.
How should a punctured Decaver vial be stored and for how long is it usable?
Store the opened Decaver vial at room temperature (15–25 °C), away from direct light and moisture. Do not refrigerate oil-based injectables after opening — cold temperatures increase viscosity and can cause the solution to cloud temporarily. Under proper aseptic handling technique, a punctured multi-dose vial remains within acceptable use for up to twenty-eight days; discard any vial showing particulate matter, discolouration, or compromised rubber septum integrity. (2) angle_used

Manufacturer

Vermodje SRL, headquartered in the Republic of Moldova, manufactures Decaver in a sterile parenteral production environment subject to ongoing GMP compliance verification. The 10 ml multi-dose vial format selected for Decaver reflects a deliberate packaging decision: compared to single-use ampoule presentation, the multi-dose vial accommodates the variable weekly volumes inherent to dose-adjustable protocols — practitioners can draw 0.8 ml one week and 1.2 ml the next without committing to fixed ampoule-sized increments. The vial's bromobutyl rubber septum withstands repeated puncture across the 28-day in-use period without compromising container-closure integrity, provided aseptic technique is maintained at each draw. HPLC potency verification and LAL endotoxin testing are completed at the batch level before distribution, with results documented in the traceable Certificate of Analysis that accompanies each Decaver production lot.

Product details

BrandVermodje
Active ingredientnandrolone decanoate
Also known asDeca Durabolin, Deca, Nandrolone Decanoate, Decaver, Vermodje Deca Durabolin
Strength250 mg
FormVial
Pack size1 piece
Item numberINJ-NAND-VER-250-025

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Decandrol 200mg/ml 10x1ml Ampoules by Balkan PharmaceuticalsEstablished Brand

Decandrol 200mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

€44.00
Deca-Durabolin 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Deca-Durabolin 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€52.00
Decadubol-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Decadubol-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€45.00
DecaTrex 350mg/ml 10ml Vial by Concentrex LabsTrusted Brand

DecaTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00